Seres Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Seres Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Seres Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $88.8M.
  • Seres Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$25.5M, a 82% increase year-over-year.
  • Seres Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$114M, a 54.5% increase from 2022.
  • Seres Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$250M, a 281% decline from 2021.
  • Seres Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$65.6M, a 26.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$25.5M $88.8M +$137M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$162M -$32.9M -$79.4M -171% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$82.7M -$40.1M +$31M +43.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$114M -$41.2M +$27.5M +40% Oct 1, 2023 Dec 31, 2023 8-K 2024-08-15
Q3 2023 -$141M -$47.9M +$12.1M +20.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$153M $46.6M +$111M Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$265M -$71.2M -$14.6M -25.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$250M -$68.8M -$18.8M -37.6% Oct 1, 2022 Dec 31, 2022 8-K 2024-08-15
Q3 2022 -$231M -$60M -$128M -188% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$103M -$64.7M -$16.4M -33.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$86.7M -$56.6M -$21.2M -59.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$65.6M -$50M -$31.7M -174% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$33.8M $68.2M +$98.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$132M -$48.3M -$27.6M -133% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$105M -$35.5M -$15.6M -78.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$89.1M -$18.3M +$526K +2.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 -$89.7M -$30.3M -$13.9M -84.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$75.8M -$20.7M -$9.96M -92.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$65.8M -$19.9M +$4.45M +18.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$70.3M -$18.8M +$2.51M +11.8% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 -$72.8M -$16.4M +$5.54M +25.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$78.3M -$10.8M +$17M +61.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$95.4M -$24.3M +$3.59M +12.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$98.9M -$21.3M +$7.67M +26.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$107M -$21.9M -$15M -216% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$91.6M -$27.8M +$231K +0.82% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$91.8M -$27.9M -$2.45M -9.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$89.4M -$29M -$3.68M -14.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$85.7M -$6.94M +$11.8M +62.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$97.5M -$28M -$105K -0.38% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$97.3M -$25.5M -$5.77M -29.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$91.6M -$25.3M -$5.64M -28.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$85.9M -$18.7M -$4.07M -27.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$81.9M -$27.9M -$15.4M -122% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$66.5M -$19.7M -$11.7M -147% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$54.8M -$19.6M -$11.5M -140% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$43.3M -$14.6M -$10.5M -251% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$32.9M -$12.6M -$9.88M -369% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$23M -$7.97M -$6.28M -372% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$16.7M -$8.18M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$4.16M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$2.68M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$1.69M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.